GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

BOM:500660 Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	41,978	38,217	37,492	34,537	32,517	32,780
Revenue Growth	13.18%	1.93%	8.56%	6.21%	-0.80%	12.05%
Gross Profit Gross Profit Growth	26,930	24,461	23,354	20,985	19,476	18,998
Operating Income Operating Income Growth	13,995	12,476	11,143	8,390	7,484	6,988
Net Income Net Income Growth	11,465	10,360	9,276	5,900	6,107	16,947
Earnings Per Share EPS Growth	67.85	61.15	54.76	34.83	36.05	100.04
EPS Growth	20.33%	11.69%	57.23%	-3.39%	-63.97%	373.19%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	37,696	36,987	33,923	31,877	31,961
Foreign Foreign Growth	520.95	504.66	614.05	640.05	818.97
Total Total Growth	38,217	37,492	34,537	32,517	32,780

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	22,185	27,568	24,981	18,568	16,541	28,309
Total Debt Total Debt Growth	392.5	332.72	99.51	186.65	155.39	200.77
Net Cash (Debt) Net Cash Growth	21,793	27,235	24,882	18,382	16,386	28,108
Net Cash Growth	7.61%	9.46%	35.36%	12.18%	-41.70%	154.93%
Net Cash Per Share Net Cash Per Share Growth	128.96	160.77	146.88	108.51	96.73	165.92

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	10,314	9,033	12,899	5,820	4,842	8,107
Capital Expenditures CapEx Growth	-649.39	-552.79	-230.22	-312.22	-440.39	-346.41
Free Cash Flow Free Cash Flow Growth	9,664	8,480	12,669	5,508	4,402	7,761
Free Cash Flow Growth	34.40%	-33.06%	130.01%	25.13%	-43.28%	45.42%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	64.15%	64.00%	62.29%	60.76%	59.89%	57.96%
Operating Margin	33.34%	32.65%	29.72%	24.29%	23.02%	21.32%
Pretax Margin	37.04%	36.79%	33.60%	23.63%	25.72%	23.77%
Profit Margin	27.31%	27.11%	24.74%	17.08%	18.78%	51.70%
FCF Margin	23.02%	22.19%	33.79%	15.95%	13.54%	23.68%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	57.000	57.000	42.000	32.000	32.000	30.000
Dividend Per Share Growth	5.56%	35.71%	31.25%	0%	6.67%	0%
Dividend Yield	2.26%	2.50%	1.46%	1.65%	2.42%	1.80%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	37.21	37.34	52.55	55.80	36.73	16.62
Forward PE	33.67	34.16	49.88	44.16	35.58	42.30
P/FCF Ratio	44.26	45.62	38.48	59.76	50.96	36.30
PS Ratio	10.19	10.12	13.00	9.53	6.90	8.59

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error